levodopa has been researched along with ketamine in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (16.67) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 7 (38.89) | 24.3611 |
| 2020's | 3 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Marmo, E | 1 |
| Anavekar, SN; Davis, HT; Tsianco, MC; Wardell, WM | 1 |
| Dimpfel, W; Spüler, M | 1 |
| Aidara, D; Robyn, C; Tahiri-Zagret, C | 1 |
| Fukumoto, D; Harada, N; Kakiuchi, T; Nishiyama, S; Ohba, H; Sato, K; Tsukada, H | 1 |
| Black, KJ; Carl, JL; Hershey, T; Perlmutter, JS | 1 |
| Anuradha, K; Hota, D; Pandhi, P | 1 |
| Khorievin, VI | 1 |
| Bartlett, MJ; Estevez, M; Falk, T; Heien, ML; Joseph, RM; Laude, ND; Lazarus, LB; LePoidevin, LM; Parent, KL; Sherman, SJ | 1 |
| Agorastos, S; Bimpisidis, Z; Cenci, MA; Dewey, SL; Eidelberg, D; Lerner, RP; Scherrer, S | 1 |
| Bimpisidis, Z; Cenci, MA; Lundblad, C; Maslava, N; Öberg, CM | 1 |
| Bartlett, MJ; Besselsen, DG; Cowen, SL; Dollish, HK; Doyle, KP; Falk, T; Farrell, DC; Flores, AJ; Heien, ML; Parent, KL; Sherman, SJ; Smidt, SI; Stancati, JA; Steece-Collier, K; Ye, T | 1 |
| Bartlett, MJ; Cowen, SL; Falk, T; Sherman, SJ; Ye, T | 1 |
| Bartlett, MJ; Falk, T; Morrison, HW; Pottenger, AE; Sherman, SJ | 1 |
18 other study(ies) available for levodopa and ketamine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Arousing agents and narcotics. Experimental study].
Topics: Anesthesia, General; Animals; Arousal; Central Nervous System Agents; Central Nervous System Stimulants; Depression, Chemical; Drug Interactions; Furosemide; Ketamine; Levodopa; Mice; Neuroleptanalgesia; Pentobarbital; Platelet Aggregation; Rabbits; Rats; Thiopental | 1978 |
Postmarketing surveillance of new drugs: II. Case studies.
Topics: Azauridine; Bacteriuria; Contraceptives, Oral; Costs and Cost Analysis; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Humans; Ketamine; Levodopa; Research Design; United States; United States Food and Drug Administration; Valproic Acid | 1979 |
Dizocilpine (MK-801), ketamine and phencyclidine: low doses affect brain field potentials in the freely moving rat in the same way as activation of dopaminergic transmission.
Topics: Amphetamine; Animals; Brain; Dibenzocycloheptenes; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Electroencephalography; Ketamine; Levodopa; Male; Membrane Potentials; Mice; Phencyclidine; Rats; Rats, Inbred F344; Synaptic Transmission; Time Factors | 1990 |
Serum prolactin concentrations in mangabey (Cercocebus atys lunulatus) and patas (Erythrocebus patas) monkeys in response to stress, ketamine, TRH, sulpiride and levodopa.
Topics: Animals; Cercopithecidae; Erythrocebus patas; Female; Humans; Ketamine; Levodopa; Male; Prolactin; Radioimmunoassay; Stress, Psychological; Sulpiride; Thyrotropin-Releasing Hormone | 1981 |
Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: multiparametric PET studies combined with microdialysis analysis.
Topics: Animals; Brain; Carbon Radioisotopes; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Extracellular Space; Ketamine; Levodopa; Macaca mulatta; Magnetic Resonance Imaging; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; Nerve Tissue Proteins; Osmolar Concentration; Raclopride; Tomography, Emission-Computed | 2000 |
Dopa-induced blood flow responses in nonhuman primates.
Topics: Anesthetics, Dissociative; Animals; Antiparkinson Agents; Arousal; Carbidopa; Cerebrovascular Circulation; Dopamine; Frontal Lobe; Gyrus Cinguli; Ketamine; Levodopa; Macaca nemestrina; Male; Papio; Parkinson Disease; Putamen; Temporal Lobe; Tomography, Emission-Computed | 2000 |
Investigation of central mechanism of insulin induced hypoglycemic convulsions in mice.
Topics: 5-Hydroxytryptophan; Animals; Anticonvulsants; Antihypertensive Agents; Blood Glucose; Dopamine; Dopamine Agents; Drug Interactions; Excitatory Amino Acid Antagonists; Excitatory Amino Acids; Hypoglycemia; Hypoglycemic Agents; Insulin; Ketamine; Ketanserin; Levodopa; Male; Mice; Reserpine; Seizures; Serotonin; Serotonin Antagonists; Survival Rate | 2004 |
[Effect of iontophoretically administered L-DOPA and ketamin on the impulse activity of the somatomotor cortex neurons during the conditioned placing movements].
Topics: Acoustic Stimulation; Animals; Cats; Conditioning, Classical; Conditioning, Operant; Evoked Potentials, Somatosensory; Iontophoresis; Ketamine; Levodopa; Neurons; Receptors, Dopamine; Receptors, N-Methyl-D-Aspartate; Somatosensory Cortex | 2010 |
Long-term effect of sub-anesthetic ketamine in reducing L-DOPA-induced dyskinesias in a preclinical model.
Topics: Animals; Antiparkinson Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Ketamine; Levodopa; Male; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid; Time Factors | 2016 |
Dissociation of metabolic and hemodynamic levodopa responses in the 6-hydroxydopamine rat model.
Topics: Analgesics; Animals; Antiparkinson Agents; Cerebrovascular Circulation; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Hemodynamics; Isoflurane; Ketamine; Levodopa; Oxidopamine; Parkinson Disease; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Sympatholytics | 2016 |
Differential effects of gaseous versus injectable anesthetics on changes in regional cerebral blood flow and metabolism induced by l-DOPA in a rat model of Parkinson's disease.
Topics: Anesthetics; Animals; Basal Ganglia; Cerebrovascular Circulation; Dyskinesia, Drug-Induced; Dyskinesias; Gases; Isoflurane; Ketamine; Levodopa; Parkinson Disease; Rats | 2017 |
Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesia.
Topics: Anesthetics, Dissociative; Animals; Antiparkinson Agents; Brain-Derived Neurotrophic Factor; Dendritic Spines; Depression; Drug Repositioning; Dyskinesia, Drug-Induced; Ketamine; Levodopa; Male; MAP Kinase Signaling System; Neurons; Rats; Rats, Sprague-Dawley; TOR Serine-Threonine Kinases | 2020 |
Spectral signatures of L-DOPA-induced dyskinesia depend on L-DOPA dose and are suppressed by ketamine.
Topics: Analgesics; Animals; Antiparkinson Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Gamma Rhythm; Ketamine; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley | 2021 |
Evaluation of microglia in a rodent model of Parkinson's disease primed with L-DOPA after sub-anesthetic ketamine treatment.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Humans; Ketamine; Levodopa; Male; Microglia; Parkinson Disease; Phagocytosis; Rats; Receptors, N-Methyl-D-Aspartate; Substantia Nigra | 2021 |